A3907

· Albireo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A3907, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis [Phase 2]